IL-13/IL-13Rα2轴促进血管肉瘤细胞的增殖
Hinako Saito1, Jason Yongsheng Chan2, Issei Omori1
1Department of Dermatology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Scientific reports
|August 25, 2025
概括
互白素-13 (IL-13) 和它的受体IL-13Rα2轴促进了血管肉瘤的生长. 针对这种IL-13/IL-13Rα2通路可能为血管肉瘤提供新的治疗策略.
科学领域:
- 癌症学
- 分子生物学
- 癌症研究
背景情况:
- 血管肉瘤是一种具有不良预后的侵袭性软组织肉瘤.
- 在血管肉瘤中,互白素-13 (IL-13) 途径的作用尚不清楚.
研究的目的:
- 研究IL-13/IL-13受体α2 (IL-13Rα2) 轴在血管肉瘤发病过程中的作用.
- 探索IL-13/IL-13Rα2轴作为血管肉瘤的潜在治疗点.
主要方法:
- 重新分析血管肉瘤的转录数据.
- 患者样本和细胞系的免疫组织化学.
- 使用血管肉瘤细胞系 (MO-LAS-B) 的体外功能研究.
- 通过siRNA介导的抗击和中和抗体.
- 使用STAT6抑制剂治疗.
主要成果:
- 在血管肉瘤组织中增加IL13RA2mRNA.
- 在血管肉瘤细胞系和患者样本中高IL-13Rα2表达.
- 通过IL-13Rα2促进血管肉瘤细胞的增殖.
- 激发IL-13可以提高IL13RA2和VEGFA的调节,这表明一种积极的反循环.
- STAT6通路参与IL-13/IL-13Rα2信号传递.
结论:
- IL-13/IL-13Rα2轴在血管肉瘤的进展中起着重要作用.
- 针对IL-13/IL-13Rα2途径为血管肉瘤提供了一个有前途的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


